Clinical Trial Update: RESCUE Study (REcurrent Ovarian Cancer Secondary Cytoreduction Using Chemotherapy rEsponse) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for the RESCUE study evaluating secondary cytoreduction using chemotherapy response in recurrent, platinum-sensitive ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Platinum-sensitive Ovarian Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Ovarian Cancer Recurrent, Platinum Sensitive Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING